OVARY CANCER
Clinical trials for OVARY CANCER explained in plain language.
Never miss a new study
Get alerted when new OVARY CANCER trials appear
Sign up with your email to follow new studies for OVARY CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug combo targets Hard-to-Treat ovarian cancer
Disease control Recruiting nowThis study tests whether two drugs, senaparib and temozolomide, can shrink tumors in people with a certain type of ovarian cancer that has an ARID1A gene change. About 18 adults with recurrent or persistent clear cell or endometrioid ovarian, fallopian tube, or primary peritoneal…
Matched conditions: OVARY CANCER
Phase: PHASE2 • Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins • Aim: Disease control
Last updated May 26, 2026 04:32 UTC
-
New drug combo aims to keep ovarian cancer at bay
Disease control Recruiting nowThis study tests whether combining two drugs, mirvetuximab soravtansine and olaparib, can effectively control recurrent ovarian, peritoneal, or fallopian tube cancer after initial treatment. About 53 women whose cancer responded to platinum-based chemotherapy will receive the dru…
Matched conditions: OVARY CANCER
Phase: PHASE2 • Sponsor: University of Colorado, Denver • Aim: Disease control
Last updated May 26, 2026 03:57 UTC
-
Supercharged immune cells take on Hard-to-Treat cancers
Disease control Recruiting nowThis study tests a new treatment for people with advanced cancers that have spread and express a protein called NY-ESO-1. Patients receive a single infusion of their own immune cells that have been genetically modified to recognize and attack cancer cells. The goal is to see if t…
Matched conditions: OVARY CANCER
Phase: PHASE1, PHASE2 • Sponsor: Hadassah Medical Organization • Aim: Disease control
Last updated May 26, 2026 03:56 UTC
-
Smart CAR t cells aim to outsmart solid tumors in new trial
Disease control Recruiting nowThis study tests a new type of CAR T cell therapy for adults with advanced solid tumors, including colorectal, pancreatic, lung, ovarian, and mesothelioma cancers. The therapy uses a patient's own immune cells, modified to recognize and attack cancer cells that have lost a specif…
Matched conditions: OVARY CANCER
Phase: PHASE1, PHASE2 • Sponsor: A2 Biotherapeutics Inc. • Aim: Disease control
Last updated May 22, 2026 14:01 UTC
-
Cherry juice may shield cancer patients from chemo nerve pain
Prevention Recruiting nowThis study tests whether drinking tart cherry juice can prevent nerve damage (neuropathy) caused by the chemotherapy drug paclitaxel in people with breast or ovarian cancer. About 86 participants will be randomly assigned to take either a high or low dose of the juice during thei…
Matched conditions: OVARY CANCER
Phase: PHASE2 • Sponsor: University of California, Davis • Aim: Prevention
Last updated May 26, 2026 04:32 UTC
-
Fasting before chemo: a new way to ease side effects?
Symptom relief Recruiting nowThis study looks at whether alternate day fasting (eating very little every other day) before chemotherapy can help reduce side effects and improve quality of life for women with ovarian, endometrial, or uterine cancer. About 30 women who have had surgery and are about to start c…
Matched conditions: OVARY CANCER
Phase: NA • Sponsor: Northwestern University • Aim: Symptom relief
Last updated May 26, 2026 03:56 UTC
-
Videos may boost genetic testing in ovarian and endometrial cancer
Knowledge-focused Recruiting nowThis study looks at whether showing short educational videos to people with ovarian or endometrial cancer can increase the number who get genetic testing. About 30 participants will watch a video about genetic testing and then fill out a satisfaction survey. Researchers will comp…
Matched conditions: OVARY CANCER
Phase: NA • Sponsor: UNC Lineberger Comprehensive Cancer Center • Aim: Knowledge-focused
Last updated May 26, 2026 04:32 UTC
-
Ovarian cancer study aims for zero colostomy bags
Knowledge-focused Recruiting nowThis study looks at whether women with advanced ovarian cancer who are at low risk for complications can safely avoid a temporary colostomy bag after part of their bowel is removed during surgery. The goal is to see if a 'no-stoma' approach is feasible without increasing dangerou…
Matched conditions: OVARY CANCER
Phase: NA • Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS • Aim: Knowledge-focused
Last updated May 26, 2026 03:55 UTC